Seres Therapeutics, Inc.
MCRB
$6.33
$0.050.80%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.91M | -15.34M | 8.20M | -19.86M | 32.68M |
| Total Depreciation and Amortization | 781.00K | 9.35M | 1.04M | 1.06M | 1.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.02M | -3.21M | 4.61M | 4.40M | 4.86M |
| Change in Net Operating Assets | -1.25M | -5.52M | -11.65M | 1.10M | -11.71M |
| Cash from Operations | -16.36M | -14.71M | 2.21M | -13.29M | 26.91M |
| Capital Expenditure | -- | -29.00K | -8.00K | -181.00K | -34.00K |
| Sale of Property, Plant, and Equipment | -- | 210.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 181.00K | -8.00K | -181.00K | -34.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 428.00K | 12.66M | 61.00K | 0.00 | 1.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 428.00K | 12.66M | 61.00K | 0.00 | 1.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.93M | -1.87M | 2.26M | -13.47M | 28.06M |